{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T02:39:03Z","timestamp":1773628743017,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.expneurol.2005.11.012","type":"journal-article","created":{"date-parts":[[2006,1,20]],"date-time":"2006-01-20T12:41:25Z","timestamp":1137760885000},"page":"136-144","source":"Crossref","is-referenced-by-count":37,"title":["Amelioration of autoimmune neuroinflammation by recombinant human alpha-fetoprotein"],"prefix":"10.1016","volume":"198","author":[{"given":"Michal","family":"Irony-Tur-Sinai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Grigoriadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Lourbopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Pinto-Maaravi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oded","family":"Abramsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talma","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2005.11.012_bib1","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1749-6632.1983.tb32855.x","article-title":"A role of alpha-fetoprotein in autoimmune diseases","volume":"417","author":"Abramsky","year":"1983","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2005.11.012_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-5728(82)90070-4","article-title":"Alpha-fetoprotein suppresses experimental allergic encephalomyelitis","volume":"2","author":"Abramsky","year":"1982","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2005.11.012_bib3","doi-asserted-by":"crossref","first-page":"6303","DOI":"10.4049\/jimmunol.164.12.6303","article-title":"Mice with a selective deletion of the CC chemokine receptors 5 or 2 are protected from dextran sodium sulfate-mediated colitis: lack of CC chemokine receptor 5 expression results in a NK1.1+ lymphocyte-associated Th2-type immune response in the intestine","volume":"164","author":"Andres","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2005.11.012_bib4","doi-asserted-by":"crossref","first-page":"6873","DOI":"10.1073\/pnas.96.12.6873","article-title":"CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions","volume":"96","author":"Balashov","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2005.11.012_bib5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0022-510X(02)00069-2","article-title":"Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease","volume":"206","author":"Bjartmar","year":"2003","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2005.11.012_bib6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0165-2478(81)90121-8","article-title":"Immunosuppression of experimental autoimmune myasthenia gravis by alpha-fetoprotein rich formation","volume":"3","author":"Brenner","year":"1981","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.expneurol.2005.11.012_bib7","first-page":"945","article-title":"Treatment of experimental allergic encephalomyelitis in rabbits with alpha-fetoprotein","volume":"21","author":"Brenner","year":"1985","journal-title":"Isr. J. Med. Sci."},{"key":"10.1016\/j.expneurol.2005.11.012_bib8","first-page":"263","article-title":"Prevention of experimental autoimmune myasthenia gravis in rats by fetal alpha-fetoprotein rich-fraction","volume":"5","author":"Brenner","year":"1985","journal-title":"Tumor Biol."},{"key":"10.1016\/j.expneurol.2005.11.012_bib9","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.4049\/jimmunol.158.6.2940","article-title":"Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis","volume":"158","author":"Brenner","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2005.11.012_bib10","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1006\/exnr.1998.6971","article-title":"Suppression of experimental autoimmune encephalomyelitis by tyrphostin AG-556","volume":"154","author":"Brenner","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2005.11.012_bib11","series-title":"Medical Complications During Pregnancy","first-page":"775","author":"Burrow","year":"1975"},{"key":"10.1016\/j.expneurol.2005.11.012_bib12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0165-5728(87)90067-1","article-title":"Experimental myasthenia gravis induced in mice by passive transfer of human myasthenic immunoglobulin. Evidence for an ameliorating effect by alpha-fetoprotein","volume":"13","author":"Buschman","year":"1987","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2005.11.012_bib13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3109\/08820139309063412","article-title":"Immuno-suppressive effect of human alphafetoprotein: a cross species study","volume":"22","author":"Chakraborty","year":"1993","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.expneurol.2005.11.012_bib14","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ncl.2004.06.003","article-title":"Myasthenia gravis and pregnancy","volume":"22","author":"Ciafaloni","year":"2004","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.expneurol.2005.11.012_bib15","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1056\/NEJM199807303390501","article-title":"Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group","volume":"339","author":"Confavreux","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2005.11.012_bib16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF02207955","article-title":"The role of pregnancy in the course and etiology of rheumatoid arthritis","volume":"11","author":"Da Silva","year":"1992","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.expneurol.2005.11.012_bib17","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/5532","article-title":"Identification of autoantibodies associated with myelin damage in multiple sclerosis","volume":"5","author":"Genain","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2005.11.012_bib18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nrn784","article-title":"New concepts in the immunopathogenesis of multiple sclerosis","volume":"3","author":"Hemmer","year":"2002","journal-title":"Nat. Rev., Neurosci."},{"key":"10.1016\/j.expneurol.2005.11.012_bib19","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/nm0997-1037","article-title":"Primary demyelination in transgenic mice expressing interferon-gamma","volume":"3","author":"Horwitz","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2005.11.012_bib20","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/0008-8749(91)90122-R","article-title":"Human alpha-fetoprotein (AFP) causes a selective down regulation of monocyte MHC class II molecules without altering other induced or noninduced monocyte markers or functions in monocytoid cell lines","volume":"133","author":"Laan-Putsep","year":"1991","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.expneurol.2005.11.012_bib21","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/1521-4141(200207)32:7<1905::AID-IMMU1905>3.0.CO;2-L","article-title":"Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein","volume":"32","author":"Lyons","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.expneurol.2005.11.012_bib22","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.4049\/jimmunol.166.7.4697","article-title":"Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice","volume":"166","author":"Mack","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2005.11.012_bib23","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.4049\/jimmunol.160.11.5588","article-title":"Prevention and treatment of experimental autoimmune encephalomyelitis by CNI-1493, a macrophage-deactivating agent","volume":"160","author":"Martiney","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2005.11.012_bib24","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000030059","article-title":"Modulation of T cell function by alpha-fetoprotein: an in vivo study on porcine thyroid peroxidase-induced experimental autoimmune thyroiditis in transgenic mice producing human alpha-fetoprotein","volume":"20","author":"Matsuura","year":"1999","journal-title":"Tumour Biol."},{"key":"10.1016\/j.expneurol.2005.11.012_bib25","first-page":"641","article-title":"Immunogold localization and analysis of IgG during immune-mediated demyelination","volume":"59","author":"Moore","year":"1988","journal-title":"Lab. Invest."},{"key":"10.1016\/j.expneurol.2005.11.012_bib26","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/j.1365-3083.1976.tb00265.x","article-title":"The effects of mouse alpha-fetoprotein on T-cell-dependent and T-cell-independent immune responses in vitro","volume":"5","author":"Murgita","year":"1976","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.expneurol.2005.11.012_bib27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neulet.2004.11.030","article-title":"Bifunctional compounds eliciting both anti-inflammatory and cholinergic activity as potential drugs for neuroinflammatory impairments","volume":"376","author":"Nizri","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2005.11.012_bib28","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/bbrc.1995.2138","article-title":"Suppression of experimental antigen-induced arthritis in transgenic mice producing human alpha-fetoprotein","volume":"213","author":"Ogata","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.expneurol.2005.11.012_bib29","first-page":"159","article-title":"Suppressive cellular and molecular activities in maternofetal immune interactions; suppressor cell activity, prostaglandins, and alpha-fetoproteins","volume":"222","author":"Olding","year":"1997","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.expneurol.2005.11.012_bib30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pep.2004.07.007","article-title":"Purification and characterization of a recombinant version of human alpha-fetoprotein expressed in the milk of transgenic goats","volume":"38","author":"Parker","year":"2004","journal-title":"Protein Expression Purif."},{"key":"10.1016\/j.expneurol.2005.11.012_bib31","series-title":"Merritt's Textbook of Neurology","article-title":"Multiple sclerosis","author":"Poser","year":"1984"},{"key":"10.1016\/j.expneurol.2005.11.012_bib32","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1172\/JCI5150","article-title":"Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients","volume":"103","author":"Sorensen","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2005.11.012_bib33","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/ni0901-762","article-title":"Multiple sclerosis: a two-stage disease","volume":"2","author":"Steinman","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.expneurol.2005.11.012_bib34","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-2990.2003.00546.x","article-title":"Cytokine-induced enhancement of autoimmune inflammation in the brain and spinal cord: implications for multiple sclerosis","volume":"30","author":"Sun","year":"2004","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.expneurol.2005.11.012_bib35","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1172\/JCI116021","article-title":"Isolation and partial characterization of a specific alpha-fetoprotein receptor on human monocytes","volume":"90","author":"Suzuki","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2005.11.012_bib36","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1002\/1521-4141(200207)32:7<1939::AID-IMMU1939>3.0.CO;2-S","article-title":"A comparative analysis of B cell-mediated myelin oligodendrocyte glycoprotein-experimental autoimmune encephalomyelitis pathogenesis in B cell-deficient mice reveals an effect on demyelination","volume":"32","author":"Svensson","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.expneurol.2005.11.012_bib37","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0161-5890(89)90141-7","article-title":"Expression of alpha-fetoprotein receptors by human T-lymphocytes during blastic transformation","volume":"26","author":"Torres","year":"1989","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.expneurol.2005.11.012_bib38","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.4049\/jimmunol.161.7.3767","article-title":"Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice","volume":"161","author":"Tran","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2005.11.012_bib39","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.4049\/jimmunol.173.3.1772","article-title":"Alpha-fetoprotein impairs APC function and induces their apoptosis","volume":"173","author":"Um","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2005.11.012_bib40","first-page":"921","article-title":"Downregulation of phorbol 12-myristate 13-acetate-induced tumor necrosis factor-alpha and interleukin-1 beta production and gene expression in human monocytic cells by human alpha-fetoprotein","volume":"22","author":"Wang","year":"1995","journal-title":"Hepatology"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448860500422X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448860500422X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T07:12:07Z","timestamp":1683357127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448860500422X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S001448860500422X"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2005.11.012","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}